• Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 23 Feb 2025 02:56:18   America/New_York


    Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 23, 2025 Share Link copied to clipboard. Shares of Viridian Therapeutics, Inc.
    Read more...
Share on,